Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease

Journal of Virology

Volumn 71, Issue 8, 1997, Pages 5723-5732

  Sheng, Nijing ^a,d   Pettit, Steve C ^b   Tritch, Radonna J ^a   Ozturk, Derya H ^a   Rayner, Marlene M ^a   Swanstrom, Ronald ^b,c   Erickson Viitanen, Susan ^a  

^a DUPONT COMPANY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CYSTEINE; DNA; EDETIC ACID; GAG PROTEIN; GENE PRODUCT; HISTIDINE; OLIGONUCLEOTIDE; PROTEINASE; RNA; ZINC FINGER PROTEIN;

ARTICLE; ESCHERICHIA COLI; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN RNA BINDING; SITE DIRECTED MUTAGENESIS; VIRION; VIRUS ASSEMBLY; VIRUS MORPHOGENESIS; VIRUS NUCLEOCAPSID; VIRUS PARTICLE;

EID: 0030738085     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.8.5723-5732.1997     Document Type: Article

References (75)

1. Aldovini, A., and R. A. Young. 1990. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1920-1926.
2. Ashorn, P., T. J. McQuade, S. Thaisrivongs, A. G. Tomasselli, W. G. Tarpley, and B. Moss. 1990. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Proc. Natl. Acad. Sci. USA 87:7472-7476.
3. Bacheler, L. T., M. Paul, M. J. Otto, P. K. Jadhav, B. A. Stone, and J. A. Miller. 1994. An assay for HIV RNA in infected cell lysates, and its use for the rapid evaluation of antiviral efficacy. Antiviral Chem. Chemother. 5:111-121.
4. Berat, C., O. Schatz, S. LeGrice, and J. L. Darlix. 1993. Analysis of the interaction of the HIV-1 replication primer tRNA(lys3) with nucleocapsid protein and reverse transcriptase. J. Mol. Biol. 231:185-190.
5. Berkowitz, R. D., J. Luban, and S. P. Goff. 1993. Specific binding of human immunodeficiency virus type 1 Gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J. Virol. 67:7190-7200.
6. Berkowitz, R. D., A. Ohagen, S. Hoglund, and S. P. Goff. 1995 Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J. Virol. 69:6445-6456.
7. Bowle, N. E., P. Damay, and P. K. Spahr. 1993. Effects of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein. J. Virol. 67:623-631.
8. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2754-2762.
9. Cheng, Y., M. H. McGowan, C. A. Kettner, J. V. Schloss, S. Erickson-Viitanen, and F. H. Yin. 1990. High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies. Gene 87:243-248.
10. Clever, J., C. Sassetti, and T. G. Parslow. 1995. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1. J. Virol. 69:2101-2109.
11. Dannull, J., A. Surovoy, G. Jung, and K. Moelling. 1994. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J. 13:1525-1533.
12. Darlix, J. L., M. Lapadat-Tapolsky, H. de Rocquigny, and B. P. Roques. 1995. First glimpses at structure-function relationships of the nucleocapsid proteins of retroviruses. J. Mol. Biol. 254:523-537.
13. de Rocquigny, H., C. Gabus, A. Vincent, M.-C. Fournie-Zaluski, B. Roques, and J.-L. Darlix. 1992. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. USA 89:6472-6476.
14. Dib-Hajj, F., R. Khan, and D. P. Geidroc. 1993. Retroviral nucleocapsid protein possess potent nucleic acid strand renaturation activity. Protein Sci. 2:232-243.
15. Dorfman, T., J. Luban, S. P. Goff, W. A. Haseltine, and H. G. Gottlinger. 1993. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 67:6159-6169.
16. Draper, D. E., I. C. Deckman, and J. V. Vartikar. 1988. Physical studies of ribosomal protein-RNA interactions. Methods Enzymol. 164:201-220.
17. Erickson-Viitanen, S., J. Manfredi, P. Viitanen, D. E. Tribe, R. Tritch, C. A. Hutchison III, D. D. Loeb, and R. Swanstrom. 1989. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease. AIDS Res. Hum. Retroviruses 5:577-591.
18. Feng, Y., T. D. Copeland, L. E. Henderson, R. J. Gorelick, W. J. Bosche, J. G. Levin, and A. Rein. 1996. HIV-1 nucleocapsid protein induces maturation of dimeric retroviral RNA in vitro. Proc. Natl. Acad. Sci. USA 93:7577-7581.
19. Gelderblom, H. R., M. Ozel, and G. Pauli. 1989. Morphogenesis and morphology of HIV structure function relations. Arch. Virol. 106:1-13.
20. Gorelick, R. J., D. J. Chabot, A. Rein, L. E. Henderson, and L. O. Arthur. 1993. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67:4027-4036.
21. Gorelick, R. J., L. E. Henderson, J. P. Hanser, and A. Rein. 1988. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl. Acad. Sci. USA 85:8420-8424.
22. Gorelick, R. J., S. M. J. Nigida, J. W. J. Bess, L. O. Arthur, L. E. Henderson, and A. Rein. 1990. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64:3207-3211.
23. Gowda, S., B. Stein, and E. Engleman. 1989. Identification of protein intermediates in the processing of the p55 HIV-1 Gag precursor in cells infected with recombinant vaccinia virus. J. Biol. Chem. 264:8459-8462.
24. Henderson, L. E., R. C. Sowder, T. D. Copeland, S. Oroszlan, and R. E. Benveniste. 1990. Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions. J. Med. Primatol. 19:411-419.
25. Housset, V., H. de Rocquigny, B. F. Roques, and J. L. Darlix. 1993. Basic amino acids flanking the zinc finger of Moloney muring leukemia virus nucleocapsid protein NCpIO are critical for virus infectivity. J. Virol. 67: 2537-2545.
26. Jamjoom, G. A., R. B. Naso, and R. B. Arlinghaus. 1976. Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. J. Virol. 19: 1054-1072.
27. Johnston, P., E. Hunter, and S. Erickson-Viitanen. Unpublished data.
28. Jowett, J. B., D. J. Hockley, M. V. Nermut, and I. M. Jones. 1992. Distinct signals in human immunodeficiency virus-type 1 Pr55 necessary for RNA binding and particle formation. J. Gen. Virol. 72:3079-3086.
29. Kageyama, S., D. T. Hoekzema, Y. Murakawa, E. Kojima, T. Shirasaka, D. J. Kempf, D. W. Norbeck, J. Erickson, and H. Mitsuya. 1994. A C2 symmetry-based HIV protease inhibitor. A77003, irreversibly inhibits infectivity of HIV-1 in vitro. AIDS Res. Hum. Retroviruses 10:735-743.
30. Kaplan, A. H., M. Manchester, L. Everitt, and R. Swanstrom. 1994. Analysis of human immunodeficiency virus type 1 protease activity in eukaryotic and bacterial cells. Methods Enzymol. 241:58-69.
31. Kaplan, A. H., J. A. Zack, M. Knigge, D. A. Paul, D. J. Kempf, D. W. Norbeck, and R. Swanstrom. 1993. Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J. Virol. 67:4050-4055.
32. Khan, R., and D. P. Giedroc. 1994. Nucleic acid binding properties of recombinant Zn2 HIV-1 nucleocapsid protein are modulated by COOH-terminal processing. J. Biol. Chem. 269:22538-22546.
33. Kohl, N. E., E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. F. Dixon, E. M. Scolnick, and I. S. Sigal. 1988. Active human immunodeficiency virus protease is required for viral inefectivity. Proc. Natl. Acad. Sci. USA 85:4686-4690.
34. Krausslich, H. G., M. Facke, A. M. Heuser, J. Konvalinka, and H. Zentgraf. 1995. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 69:3407-3419.
35. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 277:680-685.
36. Lam, W. C., A. H. Maki, J. R. Casas-Finet, J. W. Erickson, B. P. Kane, R. C. Sowder II, and L. E. Henderson. 1994. Phosphorescence and optically detected magnetic resonance investigation of the binding of the nucleocapsid protein of the human immunodeficiency virus type 1 and related peptides to RNA. Biochemistry 33:10693-10700.
37. Lambert, D. M., S. R. Petteway, Jr., C. E. McDanal, T. K. Hart, J. J. Leary, G. B. Dreyer, T. D. Meek, P. J. Bugelski, D. P. Bolognesi, B. W. Metcalf, and T. J. Matthews. 1992. Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells. Antimicrob. Agents Chemother. 36:982-988.
38. Li, M. S., A. G. Garcia, U. Bhattacharyya, P. Mascagni, B. M. Austen, and M. M. Roberts. 1996. The Vpr protein of human immunodeficiency virus type 1 binds to nucleocapsid protein p7 in vitro. Biochem. Biophys. Res. Commun. 218:352-355.
39. Li, X., Z. Gu, R. Geleziunas, L. Kleiman, M. A. Wainberg, and M. A. Parniak. 1993. Expression, purification, and RNA-binding properties of HIV-1 p15 Gag nucleocapsid protein. Protein Expression Purif. 4:304-311.
40. Luban, J., and S. P. Goff. 1991. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 Gag polyprotein. J. Virol. 65:3203-3212.
41. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
42. McBride, M. S., and A. T. Panganiban. 1996. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70:2963-2973.
43. Mely, Y., H. de Rocquigny, M. Sorinas-Jimeno, G. Keith, B. P. Roques, R. Marquet, and D. Gerard. 1995. Binding of the HIV-1 nucleocapsid protein to the primer tRNA(3Lys), in vitro, is essentially not specific. J. Biol. Chem. 270:1650-1656.
44. Mervis, R. J., N. Ahmad, E. P. Lillehoj, M. G. Raum, F. H. Salazar, H. W. Chan, and S. Venkatesan. 1988. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative Gag precursors. J. Virol. 62:3993-4002.
45. Meyers, G., J. A. Berzofsky, B. Korber, R. F. Smith, and G. N. Pavlakis. 1994. Los Alamos National Laboratory database. Los Alamos National Laboratory, Los Alamo, N.Mex.
46. Morellet, N., H. de Rocquigny, Y. Mely, N. Jullian, H. Demene, M. Ottmann, D. Gerard, J. L. Darlix, M. C. Fournie-Zaluski, and B. P. Roques. 1994. Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR. J. Mol. Biol. 235:287-301.
47. Morellet, N., N. Jullian, H. de Rocquigny, B. Maigret, J. L. Darlix, and B. P. Roques. 1992. Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR. EMBO J. 11:3059-3065.
48. Oroszlan, S., and T. B. Luftig. 1990. Retroviral proteinases. Curr. Top. Microbiol. Immunol. 157:153-185.
49. Ottmann, M., C. Gabus, and J. L. Darlix. 1995. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J. Virol. 69:1778-1784.
50. Ozturk, D. H., and S. Erickson-Viitanen. Unpublished data.
51. Pettit, S. C., M. D. Moody, R. S. Wehbie, A. H. Kaplan, P. V. Nantermet, C. A. Klein, and R. Swanstrom. 1994. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68:8017-8027.
52. Poon, D. T. K., and A. Aldovini. 1996. Charged amino acid residues of human immunodeficiency virus type-1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J. Virol. 70:6607-6616.
53. Ratner, L., A. Fisher, L. L. Jagodzinski, H. Mitsuya, R.-S. Liou, R. C. Gallo, and F. Wong-Staal. 1987. Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res. Hum. Retroviruses 3:57-69.
54. Rayner, M. M., B. C. Cordova, R. P. Meade, P. E. Aldrich, P. K. Jadhav, Y. Ru, and P. Y. Lam. 1994. DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV Gag polyprotein. Antimicrob. Agents Chemother. 38:1635-1640.
55. Reicin, A. S., S. Paik, R. D. Berkowitz, J. Luban, I. Lowy, and S. P. Goff. 1995. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J. Virol. 69:642-650.
56. Rice, W. G., J. A. Turpin, and C. A. Schaffer. 1996. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc-finger inhibitors. J. Med. Chem. 39:3606-3616.
57. Rosenberg, A. H., B. N. Lade, D. Chiu, S. Lin, J. J. Dunn, and F. W. Studier. 1987. Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene 56:125-135.
58. Ross, E. K., T. R. Fuerst, J. M. Orenstein, T. ONeill, M. A. Martin, and S. Venkatesan. 1991. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease. AIDS Res. Hum. Retroviruses 7:475-483.
59. Sakaguchi, K., N. Zambrano, E. T. Baldwin, B. A. Shapiro, J. W. Erickson, J. G. Omichinski, G. M. Clore, A. M. Gronenborn, and E. Appella. 1993. Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein. Proc. Natl. Acad. Sci. USA 90:5219-5223.
60. Schatzl, H., H. R. Gelderblom, H. Nitschko, and K. von der Helm. 1991. Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor. Arch. Virol. 120:71-81.
61. Schmalzbauer, E., B. Strack, J. Dannull, S. Guehmann, and K. Moelling. 1996. Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro. J. Virol. 70:771-777.
62. Shengi N., and S. Erickson-Viitanen. 1994. Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent. J. Virol. 68:6207-6214.
63. South, T. L., and M. F. Summers. 1993. Zinc-and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, d(ACGCC). Protein Sci. 2:3-19.
64. Surovoy, A., J. Dannull, K. Moelling, and G. Jung. 1993. Conformational and nucleic acid binding studies on the synthetic nucleocapsid protein of HIV-1. J. Mol. Biol. 229:94-104.
65. Tanchou, V., C. Gabus, V. Rogemond, and J. L. Darlix. 1995. Formation of stable and functional HIV-1 nucleoprotein complexes in vitro. J. Mol. Biol. 252:563-571.
66. Tritch, R. J., et al. Unpublished data.
67. Tritch, R. J., Y. E. Cheng, F. H. Yin, and S. Erickson-Viitanen. 1991. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein. J. Virol. 65:922-930.
68. Turner, D. H., N. Sugimoto, and S. M. Freier. 1988. RNA structure prediction. Annu. Rev. Biophys. Biophys. Chem. 17:167-192.
69. Turpin, J. A., S. J. Terpening, C. A. Schaeffer, G. Yu, C. J. Glover, R. L. Felsted, E. A. Sausville, and W. G. Rice. 1996. Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of Gag precursors and result in the release of noninfectious virus particles. J. Virol. 70:6180-6189.
70. Veronese, F. D., R. Rahman, T. D. Copeland, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1987. Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15. AIDS Res. Hum. Retroviruses 3:253-264.
71. Weiss, S., B. Konig, Y. Morikawa, and I. Jones. 1992. Recombinant HIV-1 nucleocapsid protein p15 produced as a fusion protein with glutathione S-transferase in Escherichia coli mediates dimerization and enhances reverse transcription of retroviral RNA. Gene 121:203-212.
72. Wu, W. X., L. E. Henderson, T. D. Copeland, R. J. Gorelick, W. J. Bosche, A. Rein, and J. G. Levin. 1996. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J. Virol. 70:7132-7142.
73. You, J. C., and C. S. McHenry. 1993. HIV nucleocapsid protein. Expression in Escherichia coli, purification, and characterization. J. Biol. Chem. 268: 16519-16527.
74. Zhang, Y., and E. Barklis. 1995. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J. Virol. 69:5716-5722.
75. Zuker, M. 1989. On finding the specificity of retrovirus RNA encapsidation. Science 244:48-52.